On ECHEMI
Home > Drugs > Kidney cancer
Kidney cancer
Renal tumor is the most common tumor in the urinary system, second only to bladder tumor. The vast majority of primary renal tumors are malignant, including renal cell carcinoma, Wilms tumor, and renal pelvic cancer. Benign tumors of the kidney include renal adenoma, angiomyolipoma, hemangioma, lipoma, fibroma, and juxtaglomerular cell tumor. Renal cancer is also called renal cell carcinoma, renal adenocarcinoma, clear cell carcinoma, and renal parenchymal carcinoma. Renal parenchymal carcinoma is an adenocarcinoma derived from renal tubular epithelial cells, 85% of which are clear cell carcinomas, and some are granular cell carcinomas and mixed cell carcinomas.
  • Site of disease:

    kidney
  • Infectious :

    Not contagious
  • Frequent population:

    50-70 years old with family history of smoking and alcoholism...
  • Related symptoms:

    Dull pain in waist blood in urine weight loss abdominal mass loss of appetite
  • Concurrent disease:

Related Drugs
Recombinant human interleukin-2 for injection (125Ser)
Indication: This product can be used to treat cancerous pleural and abdominal effusions and malignant tumors such as melanoma and renal cancer.
  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.